Tenaya Therapeutics, Inc.
USD0.82
-0.02 (-2.46%)
CEO
Faraz Ali
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.81
Prev. Close
$0.84
Day Low
$0.79
Day High
$0.83
52W Low
$0.53
52W High
$2.35
Market Cap
$0.14B
Volume
1.77M
| 1,650,000 |
| $0.84 |
| 29 May 2026 | Williams R Sanders | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Walsh Jeffrey T. | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Stehman-Breen Catherine | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Srivastava Deepak | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Parschauer Karah Herdman | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Lee June | director | A-Award | Acquired | 120,000 | $0.80 |
| 29 May 2026 | Burroughs Amy L. | director | A-Award | Acquired | 120,000 | $0.80 |
| 19 May 2026 | Ali Faraz | director, officer: Chief Executive Officer | S-Sale | Disposed | 3,390 | $0.79 |